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Summary
Arf1 is a GTP binding protein that functions at a num-
ber of cellular sites to control membrane traffic and
actin remodeling. Arf1 is regulated by site-specific
GTPase-activating proteins (GAPs). The combined re-
sults of crystallographic and biochemical studies [1–
3] have led to the proposal that Arf1 GAPs differ in
the specific interface formed with Arf1. To test this hy-
pothesis, we have used mutagenesis to examine the
interaction of three Arf GAPs (ASAP1, AGAP1, andArf-
GAP1) with switch 1, switch 2, and a helix3 of Arf1. The
GAPs were similar in being affected by mutations in
switch 1 and 2. However, effects of a mutation within
a helix3 and specific mutations within switch 1 and 2
differed among the GAPs. The largest differences
were observedwith a change of isoleucine 46 to aspar-
tate ([I46D]Arf1), which reduced ASAP1-induced catal-
ysis byw10,000-fold but had a 3-fold effect on AGAP1.
The reduction was due to an isolated effect on the cat-
alytic rate, kcat. In vivo [I46D]Arf1 had no detectable ef-
fect on the Golgi apparatus but, instead, functioned as
a constitutively active mutant in the cell periphery, af-
fecting the localization of ASAP1 and paxillin. Based
on our results, we conclude that the contribution of
specific residues within switch 1 of Arf to binding
and achieving a transition state toward GTP hydroly-
sis differs among Arf GAPs.
Results and Discussion
Selection, Preparation, and Analysis of Mutant
Arf1 Proteins
Mutants of Arf1 were chosen for study (see Table S1 in
the Supplemental Data available with this article online)
based on previous work that identified residues involved
*Correspondence: randazzo@helix.nih.govin effector interaction [4, 5]. These changes were primar-
ily in switch 1 and switch 2 of Arf1 (Figure 1A). We also
introduced mutations based on the crystal structure of
[D17]Arf1GDPArfGAP1 in which residues within a he-
lix3 of Arf1 formed salt bridges with Arf GAP1 [1]. The
mutant Arf proteins were expressed in and purified
from bacteria. We assessed the effects of the mutations
on protein structure as described in the Supplemental
Data.
Effect of Mutations on In Vitro Interaction with Three
Arf GAPs
GTP hydrolysis by Arf is induced by GTPase-activating
proteins (GAPs). At least 24 mammalian genes encode
proteins containing Arf GAP domains. Of these, 17 be-
long to 3 groups of protein that have demonstrated Arf
GAP activity [6, 7]. We compared three Arf GAPs that
use Arf1 as a substrate but function at different intra-
cellular sites: (1) Arf GAP1 [7]; (2) AGAP1 [8, 9]; and (3)
ASAP1 [10, 11]. [347-804]AGAP1 and [325-724]ASAP1
were used for in vitro biochemistry.
To determine the effect of the mutations in Arf1 on in-
teraction with Arf GAPs, we first determined the amount
of GAP protein required to induce hydrolysis of 50% of
the GTP bound to each Arf mutant (Table 1), called the
‘‘C50’’ in this paper [2, 3, 12]. For all three Arf GAPs, mu-
tations within switch 1 of Arf1 had a greater effect on ac-
tivity than mutations in either switch 2 or a helix3 with the
exception of Q71 (see below). Within switch 1, mutation
of isoleucine 49 to threonine affected all three GAPs 20-
to 40-fold, and mutation of asparagine 52 to alanine af-
fected all three 10- to 30-fold. Mutation of other residues
within switch 1 differentially affected GAP activity. In par-
ticular, mutation of isoleucine 46 to aspartate affected
[325-724]ASAP1 activity by z10,000-fold (we were un-
able to measure a C50, see the next paragraph and
Figure 1), Arf GAP1 activity by z30-fold, and [347-
804]AGAP1 activity by z3-fold. Mutation of phenylala-
nine 51 to tyrosine affected [347-804]AGAP1 activity
by z35-fold, [325-724]ASAP1 by 8-fold, and Arf GAP1
by 3-fold.
On titrating [325-724]ASAP1 with [I46D]Arf1, we could
not determine a C50 because the maximum hydrolysis
observed at 2 min was z30% and at 3 min was
z40%, with a half maximum effect achieved at approx-
imately 7 mM [325-724]ASAP1 (Figure 1B). One explana-
tion for these results is that, even with saturating levels
of GAP, hydrolysis was limited by time. To test this pos-
sibility, we examined a time course of the reaction with
15 mM [325-724]ASAP1 (Figure 1C). The data fit a first or-
der rate equation with 100% of the GTP on Arf1 hydro-
lyzed with a rate constant of 0.3/min. Similar results
were obtained when isoleucine 46 was mutated in the
context of a second mutation, leucine 8 to lysine (see
Table 1 and Figures 1D and 1E). The kcat, based on the
hydrolysis rate with saturating [325-724]ASAP1, was
z0.2/min (Figures 1C and 1E). The kcat, estimated by
steady-state kinetic analysis, with [L8K]Arf1 as a sub-
strate, isz30/s [12].
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(A) Structural model of Arf1. A model of Arf1 was prepared with Molscript [21] and rendered with Raster 3D [22] and coordinates from 1R8Q-Arf1
[23] with position 71 changed to glutamine. Switch 1 is yellow, switch 2 is green, and a helix3 is blue. The side chain of some of the amino acids
that were changed in mutants generated for these studies are labeled and painted white.
(B) [325-724]ASAP1 concentration dependence for GTP hydrolysis on wild-type Arf1 and [I46D]Arf1. [325-724]ASAP1 was titrated into a reaction
containing with Arf1GTP or [I46D]Arf1GTP. Reactions were stopped at 2 or 3 min, as indicated, for [I46D]Arf1 and at 3 min for wild-type protein.
(C) Time dependence of GTP hydrolysis on [I46D]Arf induced by [325-724]ASAP1. GTP hydrolysis in a reaction at 30ºC containing [I46D]Arf1GTP
and 15 mM [325-724]ASAP1 was monitored at the indicated times.
(D) [325-724]ASAP1 concentration dependence for hydrolysis of GTP on [L8K]Arf1 and [L8K,I46D]Arf1. Conditions were identical as those in (A)
but used the indicated Arf mutants.
(E) Time dependence of hydrolysis of GTP bound to [L8K,I46D]Arf1. Conditions identical to those in (C).Mutational analysis of switch 2 revealed additional dif-
ferences among the Arf GAPs. Glutamine 71 is analo-
gous to glutamine 61 in switch 2 of Ras, which has a cat-
alytic role in GTP hydrolysis. Consistent with glutamine71 of Arf1 having a similar function, [Q71L]Arf1 did not
detectably hydrolyze GTP with any GAP. Changes in
other switch 2 residues of Arf1 had no effects on interac-
tion with [347-804]AGAP1 or [325-724]ASAP1 but did
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2166Table 1. Effect of Arf Mutants on Catalytic Efficiency for GAP-Induced GTP Hydrolysis
C50 (mM) (C50 Mutant/C50 Wild-Type Indicated in Square Brackets)
Arf Protein [325-724]ASAP1 [347-804]AGAP1 Arf GAP1
Wild-Type 0.46 6 0.17 (34) [1] 0.86 6 0.041 (14) [1] 16 6 6 (11) [1]
E41Q 0.67 6 0.33 (2) [1.5] 0.72 6 0.13 (2) [0.8] 40 6 8 (2) [2.5]
I42S 0.34 6 0.18 (3) [0.7] 0.76 6 0.07 (2) [0.9] 40 6 10 (2) [2.5]
E41Q,I42S 0.24 6 0.22 (2) [0.5] 0.97 6 0.08 (2) [1.1] 37 6 6 (2) [2.3]
I46A 246 6 32 (2) [535] not done not done
I46K 78.8 6 9.5 (2) [172] 1.9 6 0.3 (2) [2.2] not done
I46D >4000a [>9000] 2.9 6 0.3 (2) [3.4] 471 6 34 (2) [29]
I49T 13 6 4 (4) [28] 18.6 6 2.1 (2) [22] 690 6 70 (2) [43]
F51Y 3.9 6 1.6 (3) [8] 32 6 5 (2) [37] 55 6 11 (2) [3]
N52A 5.8 6 2.3 (2) [13] 12.2 6 2.8 (2) [15] 460 6 34 (2) [29]
Q71L no activityb no activityc no activityd
D72A 0.70 6 0.09 (3) [1.5] 1.2 6 0.16 (2) [1.4] 75 6 20 (2) [4.7]
K73A 0.60 6 0.4 (4) [1.3] 1.1 6 0.13 (2) [1.3] 61 6 10 (2) [3.8]
R79G 0.63 6 0.26 (4) [1.4] 1.74 6 0.38 (2) [2] not done
Y81H 0.51 6 0.38 (2) [1.1] 0.45 6 0.06 (2) [0.5] 40 6 6 (2) [2.5]
Q83R 0.27 6 0.07 (2) [0.6] 1.58 6 0.25 (2) [1.8] 12 6 5 (2) [0.8]
E105A 0.43 6 0.05 (2) [0.09] 0.74 6 0.076 (2) [0.9] 25 6 4 (2) [1.5]
E106A 1.0 6 0.5 (3) [2.2] 1.38 6 0.35 (2) [1.6] 114 6 13 (2) [7]
R109A 0.43 6 0.14 (3) [0.9] 1.5 6 0.38 (2) [1.7] not done
D114A 0.64 6 0.18 (2) [1.4] 0.46 6 0.15 (2) [0.5] 22 6 6 (2) [1.4]
L8K 0.31 6 0.022 (5) [0.7] 0.67 6 0.04 (3) [0.8] not done
L8K,I46D >4000a [>9000] 1.86 6 0.22 (2) [2.2] not done
L8K,I49T 28 6 4 (4) [61] 9.6 6 0.9 (3) [11] not done
L8K,F51Y 3.6 6 0.5 (2) [7.8] 22.9 6 3.4 (3) [27] not done
L8K,Q71L no activityb no activityc not done
L8K,E106A 0.29 6 0.1 (2) [0.6] 1.24 6 0.17 (2) [1.4] not done
The amount of the indicated Arf GAP needed to induce hydrolysis of 50% of the GTP bound to the indicated Arf1 protein in 3 min was determined
as described in Supplemental Experimental Procedures. Averages and standard deviations are presented. The number of experiments per-
formed is indicated in parentheses. C50 mutant/C50 wild-type indicated in square brackets.
a Did not achieve 50% hydrolysis in these fixed time point assays.
b No activity with 10 mM [325-724]ASAP1.
c No activity with 1 mM [347-804]AGAP1.
d No activity with 2 mM ArfGAP1.affect interaction with Arf GAP1. Mutational analysis of
a helix3 also revealed differences between the GAPs.
Mutation of glutamate 106 affected interaction with
[347-804]AGAP1 and [325-724]ASAP1 by 2- to 3-fold
but had an z7-fold effect on the interaction with Arf
GAP1. a helix3 mutants affected activity less than did
switch 1 mutants, an unexpected result given the crystal
structure [1].
We focused on [325-724]ASAP1 and [347-804]AGAP1
and five Arf mutants, [I46D]Arf1, [I49T]Arf1, [F51Y]Arf1,
[Q71L]Arf1, and [E106A]Arf1, for further study. Except
for the latter, each of these had a greater C50 than
wild-type Arf1 with either [325-724]ASAP1 or [347-
804]AGAP1. The differences could result from either a
change in the catalytic constant (kcat), affinity (Kd), or
both. Here, we examined the effects of mutations on
Kds. For these experiments, we introduced a second mu-
tation into Arf1, changing leucine 8 to lysine. In contrast
to wild-type Arf1, [L8K]Arf1 loads efficiently with GTP
in vitro ([2] and see Table S1). Furthermore, [L8K]Arf1 is
easily expressed and purified in large amounts, and
[L8K]Arf1 and wild-type Arf1 are similar when using
[325-724]ASAP1, [347-804]AGAP1, or Arf GAP1 as an en-
zyme under the assay conditions used in these studies
[2]. Based on nucleotide binding (Table S1) and CD spec-
tra (Figure S1B), the second mutations had no detectable
effect on the structure of [L8K]Arf1. The change at leu-
cine 8 did not affect the C50s for [I46D]Arf1, [F51Y]Arf1,or [Q71L]Arf1 and affected the C50s for [I49T]Arf1 and
[E106A]Arf1 by 2- to 3-fold (Table 1).
Affinity of [L8K]Arf1 for GAP was determined by the
use of [L8K]Arf1GTPgS as a competitive inhibitor of
GAP activity. With limiting amounts of Arf1GTP pres-
ent, the concentration of [L8K]Arf1GTPgS that inhibits
activity by 50% is a measure of affinity, Kd. We first
examined [325-724]ASAP1 (Table 2). We found that
Table 2. Affinity of Arf Mutants for [325-724]ASAP1 and
[347-804]AGAP1
Kd
Arf1 Protein [325-724]ASAP1 [347-804]AGAP1
L8K 5.3 6 0.78 (3) 2.2 6 0.26 (6)
L8K,I46D 3.1 6 0.4 (3) 1.3 6 0.21 (3)
L8K,I49T no inhibition (3) 7.5 6 1.0 (3)
L8K,F51Y >10* (3) no inhibition (3)
L8K,Q71L 3.2 6 0.27 (3) 1.3 6 0.28 (3)
L8K,E106A 3.1 6 0.44 (3) 1.7 6 0.22 (3)
The affinity of Arf1 with GTPgS bound for the indicated GAP was de-
termined by a competition assay as described in the text and in Sup-
plemental Experimental Procedures. Asterisk indicates less than
20% inhibition was observed at 10 mM Arf1GTPgS. No inhibition in-
dicates that we could not detect any change in activity with
Arf1GTPgS at concentrations of 10 mM. Averages and standard de-
viations for the values obtained in the number of experiments indi-
cated in parentheses are presented.
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(A) b-COP. Arf1 protein containing an HA epitope tag at the carboxyl terminus [24] was expressed in NIH 3T3 fibroblasts. After 24 hr, cells were
treated for 2 min with 100 mg/ml brefeldin A. Cells were fixed and Arf1 and b-COP were visualized by immunofluorescence.
(B) Focal adhesions. The indicated Arf1 protein with an HA epitope tag was expressed in NIH 3T3 fibroblasts and proteins and either paxillin or
ASAP1 were visualized.[L8K,E106A]Arf1, which had a similar C50 as [L8K]Arf1,
also had a similar Kd. Consistent with a catalytic func-
tion, mutation of glutamine 71 did not reduce the affinity
of Arf1 for GAP. [L8K,F51Y]Arf1 and [L8K,I49T]Arf1 had
lower affinities for [325-724]ASAP1 than did [L8K]Arf1,
consistent with switch 1 mediating binding between
Arf and Arf GAP. [L8K,I46D] bound [325-724]ASAP1
with an affinity similar to that of [L8K]Arf1 (Table 2).
Based on the lack of effect of mutating isoleucine onKd but the large effect on the kcat, we conclude that,
analogous to the P loop residue glycine 12 in Ras, iso-
leucine 46 is not involved in forming the ground state
complex but is important to forming the transition state
complex [13, 14].
The effects of the mutations in Arf on affinity for [347-
804]AGAP1 were similar, but not identical, to the effects
observed for [325-724]ASAP1 (Table 2). Change of iso-
leucine 46 had no detectable effect on affinity. [L8K,
Current Biology
2168Q71L]Arf1 had a slightly greater affinity for [347-
804]AGAP1 than did [L8K]Arf1. Mutation of either isoleu-
cine 49 or phenylalanine 51 affected affinity. However,
for [347-804]AGAP1, the reduction was greater with
change of phenylalanine 51 compared to isoleucine 49;
for [325-724]ASAP1, the converse was true. Based on
these results, we conclude that isoleucine 49 and phe-
nylalanine 51 have differential effects on binding to
[325-724]ASAP1 and [347-804]AGAP1. Isoleucine 46
has a greater role in achieving a transition state toward
GTP hydrolysis in the Arf/[325-724]ASAP1 complex
than in the Arf/[347-804]AGAP1 complex.
In Vivo Expression of [I46D]Arf1 and Other
Arf1 Mutants
Our in vitro studies indicated that isoleucine 46 had
a greater influence on catalysis by [325-724]ASAP1
than other Arf GAPs. To exclude the possibility that the
in vitro results were consequent to a nonphysiological
context, we expressed the Arf mutants in cultured cells
and determined their localization and effect on organ-
ellar markers. We found that HA-tagged [I46D]Arf1
([I46D]Arf1-HA) was diffusely distributed with some pro-
tein at the edge of the cell (arrow, Figure 2A, observed in
68% of 100 cells expressing [I46D]Arf1-HA, compared to
6% expressing wild-type Arf1-HA). The distribution of
b-COP was not grossly affected, although it was some-
times found at the cell edge (arrow, Figure 2A, 32% of
cells expressing [I46D]Arf1-HA compared to <2% with
Arf1-HA). ASAP1 affects focal adhesions [11, 15, 16].
Consistent with a defect in ASAP1 function, [I46D]Arf1-
HA expression led to the alteration of the structure of
focal adhesions (Figure 2B). Instead of being in linear
structures behind the edge of the cell (ASAP1 distribu-
tion in nontransfected cells shown in Figure S2),
ASAP1 (arrowheads in Figure 2B) and paxillin (small ar-
rowheads), a marker of focal adhesions, were at the
edge of the cell. The effect was not the result of the epi-
tope tag on Arf1. Overexpressed Arf1-HA colocalized, in
a perinuclear distribution, withb-COP (Figure 2A) and did
not affect the localization of ASAP1 or paxillin, indicated
by arrows in Figure 2B. [Q71L]Arf1, which is not a produc-
tive substrate for any of the GAPs we examined, also dis-
rupted ASAP1 and paxillin localization (Supplemental
Data).
The mislocalization of b-COP at the cell edge with
[I46D]Arf1 was consistent with [I46D]Arf1 being bound
to GTP (see Figure 2A). To examine the nucleotide bind-
ing status of [I46D]Arf1, we coexpressed it with GFP-
GATGGA3, green fluorescent protein bound to a fragment
of GGA3 that binds to Arf1GTP but not Arf1GDP [3, 5,
17] and, therefore, can be used as an indicator of
Arf1GTP. Consistent with [I46D]Arf1-HA being bound
to GTP, GFP-GATGGA3 colocalized with it at the cell
edge (Figure S4).
We also examined the effect of [I46D]Arf1-HA expres-
sion on brefeldin A (BFA)-induced Golgi dissolution.
BFA is a fungal metabolite that inhibits Arf1 exchange
factors functioning at the Golgi apparatus [18]. Treat-
ment of cells with BFA results in dissolution of the Golgi
apparatus dependent on the hydrolysis of GTP on Arf1
induced by Arf GAP1. Expression of an Arf mutant, like
[Q71L]Arf1, unable to hydrolyze GTP, slows the effects
of BFA on the Golgi (Supplemental Data). In contrast,expression of [I46D]Arf1-HA had no detectable effect
on BFA-induced Golgi dissolution (Figure 2A), as would
be predicted for Arfs that can be used as a substrate by
Arf GAP1. In addition, [I46D]Arf-HA did not dissociate
from the edge of the cell on BFA treatment. Although an-
other important contributing factor for the lack of
[I46D]Arf1-HA association with or effect on the Golgi
apparatus may be poor interaction with exchange fac-
tors (switch 1 is critical to binding guanine nucleotide
exchange factors [19]), the data are consistent with
(1) [I46D]Arf1 being a poor substrate for ASAP1 and
(2) [I46D]Arf1 acting as a constitutively active Arf specif-
ically at the plasma membranes.
We have postulated that these differences in the Arf
GAPs are important for site-specific function of Arf1.
Arf GAPs function to inactivate Arf in the presence of
a variety of effectors, which do not have a common Arf
binding site [4, 20]. The Arf binding site for Arf GAP
may vary to accommodate these differences. Variation
in the interface might also reflect different functions of
the Arf GAPs. Although Arf GAPs function as Arf inac-
tivators, they can have additional functions. ASAP1
bends membranes on binding ArfGTP (Z. Nie et al.,
submitted). Isoleucine 46 of Arf1 could be involved in ei-
ther driving or regulating the conformational transition
from ArfGTP binding to GTP hydrolysis/catalysis,
which may accompany the change from a flat to a curved
surface.
Supplemental Data
Supplemental Data include four figures, two tables, and Supplemen-
tal Results and Experimental Procedures and can be found with this
article online at http://www.current-biology.com/cgi/content/full/
15/23/2164/DC1/.
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